C12N 2770/24162
By genetic engineering
Official title: by genetic engineering
C12N2770/24162 (By genetic engineering) appears on 63 US grants and 89 published applications in this corpus.
Search patents in C12N- Granted patents
- 63
- Published applications
- 89
- Assignees
- 64
- Inventors
- 135
- Latest grant
- 21 Jan 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 2 | 3 |
| 2005 | 1 | 4 |
| 2006 | 0 | 0 |
| 2007 | 2 | 2 |
| 2008 | 3 | 3 |
| 2009 | 2 | 4 |
| 2010 | 2 | 3 |
| 2011 | 2 | 3 |
| 2012 | 3 | 5 |
| 2013 | 0 | 5 |
| 2014 | 8 | 4 |
| 2015 | 3 | 3 |
| 2016 | 3 | 1 |
| 2017 | 2 | 3 |
| 2018 | 4 | 7 |
| 2019 | 7 | 8 |
| 2020 | 4 | 6 |
| 2021 | 2 | 3 |
| 2022 | 4 | 5 |
| 2023 | 3 | 4 |
| 2024 | 4 | 6 |
| 2025 | 2 | 5 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Development of dengue virus vaccine components21 Jan 2025US 12,203,100 B2The Government of the U.S.A. as represented by the Secretary of the Dept. of Health & Human Services
- Compositions and methods for dengue virus chimeric constructions in vaccines7 Jan 2025US 12,186,363 B2Takeda Vaccines, Inc.
- Attenuated flaviviruses17 Dec 2024US 12,168,049 B2Codagenix Inc.
- Modulation of replicative fitness by deoptimization of synonymous codons17 Sep 2024US 12,090,197 B2The Government of the USA, as represented by the Secretary, Department of Health and Human Services
- Viral synthetic nucleic acid sequences and use thereof20 Aug 2024US 12,065,651 B2Synvaccine Ltd.
- Use of dengue vaccine in pregnant and/or breastfeeding subjects23 Apr 2026US 2026/0108594 A1Takeda Vaccines, Inc.
- Combination therapy of oncolytic virus drugs for cancer treatment26 Feb 2026US 2026/0053873 A1Sichuan Oncocare Biopharmaceutical, Inc.
- Chimeric zika virus anticancer vaccine obtained through breast cancer cell passage25 Sep 2025US 2025/0295750 A1
- Self-amplifying mrna vaccine based on z7 genome14 Aug 2025US 2025/0255952 A1The University of Southern Mississippi
- Development of dengue virus vaccine components24 Jul 2025US 2025/0236848 A1The Government of the U.S.A. as represented by the Secretary of the Dept. of Health & Human Services
Most cited
By later US patents
- Chimeric west nile/dengue viruses52US 8,715,689 B2The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · 2014
- Chimeric flavivirus vaccines35US 6,696,281 B1Acambis Inc. · 2004
- Modulation of replicative fitness by deoptimization of synonymous codons20US 8,846,051 B2The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · 2014
- Chimeric flavivirus vaccines19US 6,962,708 B1Acambis Inc. · 2005
- Pseudoinfectious flavivirus and uses thereof15US 8,252,574 B2Board of Regents, The University of Texas System · 2012